The Billion Dollar Opportunity Hidden in Existing Medicines
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
The $Billion Opportunity Hidden in Existing Medicines: CEO Sreevatsa Natarajan on The HealthAlpha Podcast
In a recent episode of The HealthAlpha Podcast, Revio Therapeutics Co-Founder & CEO Sreevatsa Natarajan had a discussion with host Sushaant Bakhru to discuss the massive, untapped "middle lane" of the pharma industry, the space bridging generic drugs and high-risk, blockbuster drug discovery.
Drawing on over 25 years of global R&D leadership, Mr.Vatsa shares how Revio is rewriting the rules of drug development by utilizing advanced formulations, capital-efficient regulatory pathways, and our proprietary AI platform, rethink Tx™, to transform clinically validated molecules into faster, lower-risk innovations for patients with severe unmet needs. It’s a masterclass on the future of specialty pharma, building defensible IP, and accelerating the bench-to-bedside timeline.
Listen to the full episode or learn more about our pipeline by connecting with our team.
Partner With Us
At Revio we have the passion & expertise to develop successful drugs that improve patients’ lives & create value for all stakeholders. And we value partnerships that are mutually accretive and help us succeed in our mission.
For Researchers
Have an idea or IP ready for development? Partner with us to turn it into a reality.
For Pharmaceutical and Biotech Companies
Let’s join forces to bring cutting-edge programs to the finish line.
For Investors
Be part of our mission to revolutionize drug development and deliver measurable impact.